TY - JOUR
T1 - Long-acting formulations
T2 - A promising approach for the treatment of chronic diseases
AU - Kumar, Somaraju R.
AU - Mehta, Chetan H.
AU - Nayak, Usha Y.
N1 - Funding Information:
The study was funded by the Life Sciences Inc., (Grant ID. IG0617003), USA.
Publisher Copyright:
© 2021 Bentham Science Publishers.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021
Y1 - 2021
N2 - Medication and patient adherence are the two main aspects of any successful treatment of chronic disease. Even though diseases and its treatment existed for several hundred years, the treatment optimization for a given patient is still a researcher question for scientists. There are differences in treatment duration, prognos-tic signs and symptoms between patient to patient. Hence, designing ideal formulation to suit individual patient is a challenging task. The conventional formulations like oral solids and liquids gives a partial or incomplete treatment because the patient needs to follow the daily pills for a longer time. In such cases, the long-acting formulations will have better patient compliances as drug will be released for a longer duration. Many such approaches are under the clinical investigation. The favorable pharmacokinetic and pharmacodynamic relation-ships, will be promising option for the treatment of chronic diseases. In this review, we have highlighted the importance of long-acting formulations in the treatment of chronic diseases and the advent of newer formulation technologies.
AB - Medication and patient adherence are the two main aspects of any successful treatment of chronic disease. Even though diseases and its treatment existed for several hundred years, the treatment optimization for a given patient is still a researcher question for scientists. There are differences in treatment duration, prognos-tic signs and symptoms between patient to patient. Hence, designing ideal formulation to suit individual patient is a challenging task. The conventional formulations like oral solids and liquids gives a partial or incomplete treatment because the patient needs to follow the daily pills for a longer time. In such cases, the long-acting formulations will have better patient compliances as drug will be released for a longer duration. Many such approaches are under the clinical investigation. The favorable pharmacokinetic and pharmacodynamic relation-ships, will be promising option for the treatment of chronic diseases. In this review, we have highlighted the importance of long-acting formulations in the treatment of chronic diseases and the advent of newer formulation technologies.
UR - http://www.scopus.com/inward/record.url?scp=85102471387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102471387&partnerID=8YFLogxK
U2 - 10.2174/1381612826666200707122012
DO - 10.2174/1381612826666200707122012
M3 - Review article
C2 - 32634073
AN - SCOPUS:85102471387
SN - 1381-6128
VL - 27
SP - 876
EP - 889
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 6
ER -